Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
07:23a PORVAIR : Non-Executive Director Buys First Shares (DIRECTOR DEALINGS)
07:23a Global Boardsports - Strategic Business Report 2015
07:22a AK TRANSAERO : Transaero Airlines announces its operational results for 2014
07:21aDJIndia Shares Rise to New High
07:21a RESEARCH AND MARKETS : Global Light Vehicle OE Wheels Market Report 2015
07:20a CITIGROUP : Sustaining returns in an uneven recovery – Citi Private Bank's views
07:20a SICO Fixed Income Fund outperforms regional benchmark in 2014
07:20a SAUDI BRITISH BANK : HSBC-backed SABB expects slower growth for Saudi banks this year
07:20a SALAMANDER ENERGY : Form 8.5 (EPT/NON-RI) Salamander Energy plc
07:20a SALAMANDER ENERGY : Form 8.5 (EPT/RI) Salamander Energy Plc
Latest news
Advertisement
Hot News 
VOLGA GAS : Says No Longer For Sale; Costs To Fall In Line With Revenue
P2P GLOBAL INVESTMENTS : Raises GBP250 Million In C Share Issue (ALLISS)
BENCHMARK : Swings To Loss As It Ramps Up Operations
ANGLE : Says Patient Data Backs Parsortix Use To Detect Ovarian Cancer
AFREN : Funding Problems Worsen As It Enters Talks With Bondholders (ALLISS)
Most Read News
01/26 NATUREX : takes driver position in quillaia market
01/26 AER LINGUS TO RECOMMEND $1.5 BLN OFFER FROM BA-OWNER : Rte
12:17aDJBLOOMBERRY RESORTS : Buys 12.2-Hectare Property in South Korea
01/26 Qantas lifts base ticket prices to offset dropping of fuel surcharge
03:35a SMA Solar to cut 1,600 jobs as European demand slides
Most recommended articles
07:21aDJIndia Shares Rise to New High
07:20a Dentons, Dacheng merge to create world’s biggest law firm
07:20aDJIndian Military's Aging Equipment in Focus as Fighter Jet Crashes
07:17a Swiss-based Sunrise sets price range for market debut
07:16aDJDuPont Warns of Currency Headwinds -- 2nd Update
Dynamic quotes  
ON
| OFF